微信关注
Total item
Cart Subtotal
￥ 0.00 Raf
| Catalog No. | Inhibitor Name | Raf | C-Raf/Raf-1 | B-Raf | A-raf | Other |
|---|---|---|---|---|---|---|
| A10739 | Vemurafenib | * | ** | SRMS,ACK1,MAP4K5 (KHS1) | ||
| A10002 | PLX-4720 | *** | *** | BRK,FRK,CSK | ||
| A11381 | Dabrafenib | **** | **** | |||
| A10420 | GDC-0879 | **** | ||||
| A10773 | RAF265 | ** | VEGFR2 | |||
| A11063 | AZ 628 | ** | ** | |||
| A10661 | NVP-BHG712 | * | EphB4,c-Src,c-Abl | |||
| A10829 | SB590885 | **** | ||||
| A11077 | ZM 336372 | * | ||||
| A10001 | Sorafenib | **** | ** | mVEGFR2(Flk1),mVEGFR3,mPDGFRβ | ||
| A11436 | GW5074 | *** | ||||
| A13323 | TAK-632 | **** | *** | Aurora B,PDGFRβ,FGFR3 | ||
| A13772 | CEP-32496 | ** | *** | RET,PDGFRβ,LCK | ||
| A13226 | Encorafenib | **** | ||||
| A14019 | RO5126766 | * | *** | MEK1 | ||
| A15855 | PLX7904 | |||||
| A11240 | MLN2480 | |||||
| A10250 | Regorafenib (BAY 73-4506) | **** | ** | FGFR1, Kit, PDGFRβ, RET, Tie-2 , VEGFR1, VEGFR2, VEGFR3 | ||
| A11211 | ML 786 dihydrochloride | **** | **** | Abl-1, DDR2, EPHA2, RET, PERK | ||
| A12739 | PF-04880594 | **** | **** | |||
| A13525 | L-779450 | **** | p38α, GSK3β, Lck |
Notes:
1.Hover mouse over "" to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of "" is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
44 个项目
每页
-
RO5126766 (CH5126766)
Catalog No. A14019 Raf/MEK dual 抑制剂RO5126766 (CH5126766)是对Raf和MEK丝裂原激活的蛋白激酶（MAPK）具有特异性的蛋白激酶抑制剂，具有潜在的抗肿瘤活性。 了解更多 -
B-Raf-inhibitor 1
Catalog No. A14122 B-Raf 抑制剂B-Raf inhibitor 1是有效的选择性B-Raf抑制剂，对A375增殖和A375 p-ERK的细胞IC50分别为0.31 uM和2 nM。 了解更多 -
CEP-32496 hydrochloride
Catalog No. A15040 Raf 抑制剂CEP-32496 hydrochloride是野生型BRAF，V600E突变型BRAF和c-Raf的高效抑制剂，Kd值分别为14 nM，36 nM和39 nM。 了解更多 -
Dabrafenib Mesylate
Catalog No. A15059 Raf 抑制剂Dabrafenib Mesylate是一种新颖，有效和选择性的Raf激酶抑制剂，能够抑制野生型B-Raf，B-RafV600E和c-Raf的激酶活性，IC50值分别为3.2、0.8和5.0 nM。 了解更多 -
ML 786 dihydrochloride
Catalog No. A11211 Raf 抑制剂ML 786 dihydrochloride是一种有效的Raf激酶抑制剂（B-RafV600E，C-Raf和野生型B-Raf的IC50值分别为2.1、2.5和4.2 nM）。 了解更多 -
HG6-64-1
Catalog No. A16022 -
RAF mutant-IN-1
Catalog No. A19011 Raf nhibitorRAF mutant-IN-1 is a RAF kinase inhibitor, extracted from patent WO2019107987A1, with IC50 values of 21 nM, 30 nM and 392 nM for C-RAF340D/Y341D, B-RAFV600E and B-RAFWT, respectively. 了解更多 -
Belvarafenib
Catalog No. A13177 pan RAF inhibitorBelvarafenib (HM95573) is a potent and pan RAF (Rapidly Accelerated Fibrosarcoma) inhibitor, with IC50s of 56 nM, 7 nM and 5 nM for B-RAF, B-RAFv600E and C-RAF respectively. 了解更多 -
Regorafenib Hydrochloride
Catalog No. A11546 VEGFR1/2/3/PDGFRβ/Kit/RET/Raf-1 inhibitorRegorafenib Hydrochloride is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively. 了解更多 -
B-Raf IN 1
Catalog No. A21055 B-Raf kinase inhibitorB-Raf IN 1 is a potent and selective B-Raf kinase inhibitor with an IC50 of 24 nM. 了解更多 -
B-Raf inhibitor 1 dihydrochloride
Catalog No. A21834 Raf kinase inhibitorB-Raf inhibitor 1 dihydrochloride is a potent Raf kinase inhibitor with Kis of 1 nM, 1 nM, and 0.3 nM for B-RafWT, B-RafV600E, and C-Raf, respectively. 了解更多 -
Lifirafenib
Catalog No. A20988 Raf/EGFR inhibitorLifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively. 了解更多 -
Regorafenib (BAY 73-4506)
Catalog No. A10250 VEGFR 抑制剂Regorafenib (BAY 73-4506)是一种多激酶抑制剂，IC50为17、40和69 nM c-KIT，VEGFR2，B-Raf。Regorafenib（BAY 73-4506）是一种针对肿瘤及其脉管系统的口服生物利用型多激酶抑制剂。 了解更多 -
Sorafenib Tosylate (Nexavar)
Catalog No. A10001 Raf 抑制剂Sorafenib Tosylate (Nexavar)是几种酪氨酸蛋白激酶(VEGFR和PDGFR)和RAF/MEK/ERK级联抑制剂的新型小分子抑制剂，Raf-1，wt BRAF和V599E突变型BRAF的IC50为6、22、38 nM。 了解更多 -
PLX4032 (Vemurafenib)
Catalog No. A10739 Raf 抑制剂PLX4032(Vemurafenib)也称为RG7204，Vemurafenib，R7204，RO5185426。PLX4032是B-raf抑制剂，IC50为44 nM。 了解更多 -
NVP-BHG712
Catalog No. A10661 EphB4 抑制剂NVP-BHG712是EphB4激酶的选择性抑制剂，在体外对EphB4的选择性超过40多种其他激酶（包括FGFR3）。 了解更多 -
Dabrafenib (GSK2118436A)
Catalog No. A11381 Raf 抑制剂Dabrafenib (GSK2118436A)是一种有效且选择性的B-RAF蛋白激酶抑制剂，具有V600E突变，目前正在临床试验中。 了解更多 -
Balamapimod (MKI-833)
Catalog No. A13119 -
LGX 818 (Encorafenib)
Catalog No. A13226 Selective B-RAF 抑制剂LGX 818 (Encorafenib)是一种Raf激酶抑制剂，具有潜在的抗肿瘤活性。 了解更多 -
L-779450
Catalog No. A13525 -
RAF265 (CHIR-265)
Catalog No. A10773 RAF/VEGFR 抑制剂RAF265 (CHIR-265)是一种口服，高度选择性的RAF和VEGFR激酶抑制剂，可控制或正常化VEGFR-2，同时抑制B-raf和c-Raf突变以预防癌症。 了解更多 -
GDC-0879
Catalog No. A10420 -
AZ628
Catalog No. A11063 -
SB590885
Catalog No. A10829 -
ZM 336372
Catalog No. A11077 -
-
最新产品
AZ304
Catalog No. A17225 dual BRAF 抑制剂AZ304 is a potent dual BRAF inhibitor targeting the kinase domains of wild type BRAF, V600E mutant BRAF. AZ304 exerted potent inhibitory effects on both wild type and V600E mutant forms of the serine/threonine-protein kinase BRAF, with IC50 values of 79?nM and 38?nM, respectively. 了解更多 -
-
Lifirafenib (BGB-283)
Catalog No. A16844 BRAF 抑制剂Lifirafenib (BGB-283)，也称为Beigene-283，在生化分析中有效抑制RAF家族激酶和EGFR活性，重组BRAFV600E激酶结构域，EGFR和EGFR T790M/L858R突变体的IC50值为23、29和495 nM。 了解更多 -
LXH254
Catalog No. A16841 -
Locostatin
Catalog No. A16079 -
Diazepinomicin
Catalog No. A12891 -
Raf265 derivative
Catalog No. A10774 RAF/VEGFR 抑制剂Raf265 derivative是Raf265的衍生物，Raf265是一种口服，高度选择性的RAF和VEGFR激酶抑制剂，IC50为5至10μM。 了解更多 -
Regorafenib monohydrate
Catalog No. A15218 Tyrosine kinase 抑制剂Regorafenib monohydrate是VEGFR1/VEGFR2/VEGFR3/PDGFRβ/Kit/RET和Raf-1的多靶点抑制剂，IC50分别为13 nM/4.2 nM/46 nM/22 nM/7 nM/1.5 nM和2.5 nM。 了解更多 -
GW 5074
Catalog No. A11436 -
MLN2480 (BIIB-024)
Catalog No. A11240 -
PF-04880594
Catalog No. A12739
44 个项目
每页
FILTER BY:
购物选项
- 作用机制
-
- Inhibitor (抑制剂) (44)
- 靶点
ADOOQ 产品质量保证
We promise all products to perform as described.